Lung Cancer Clinical Trial
Official title:
Fast Tracking in VATS Lobectomy: A Prospective, Historically Controlled, Propensity-Matched Clinical Trial
Currently, at the CHUM - Notre-Dame Hospital, there is no standardized patient care pathway
for patients undergoing Video Assisted Thoracic Surgery (VATS) lobectomy. The investigators
goal is to implement an Enhanced Recovery Program (ERP) for patient undergoing VATS
lobectomy.
The care given to patient prior to the implementation of this protocol was different amongst
patients and depended on the surgeon's preferences. The implementation of this ERP will
permit a reproducible and routine management for patients following their surgery.
Lung cancer is the most common cause of cancer related death in men and women worldwide
annually. In North America in 2009, an estimated 246,000 people were diagnosed with lung
cancer, and 178,000 died as a result. Lobectomy consists of the surgical removal of an
anatomic lobe of the lung. It represents the standard of care in the treatment of malignant
lesions involving one lobe of the lung. This operation can be performed either with a chest
incision with rib spreading (thoracotomy) or with a minimally invasive approach which does
not include rib spreading (thoracoscopy - Video Assisted Thoracoscopic Surgery; VATS).
In the last decade, the trend towards implementation of protocols to enhance patient recovery
and diminish length of stay has been gaining popularity and increasing in prevalence. Those
protocols are commonly referred to as fast track surgery or enhanced recovery after surgery
protocol. The rationale behind these protocols is that by combining multimodal therapies that
reduce surgical stress, having good pain control post-operatively, and involving the patient
in this process, the treating team has the potential to reduce length of stay.
In the last few years, many surgeons in their respective centers have implemented the use of
fast track surgery in the thoracic surgery service. It has been shown to be a safe and
effective method for managing postoperative patients after lobectomy. Fast track surgery is a
systemic approach to the management of surgical patients, where all the different actions to
take postoperatively are standardized and reproducible. Fast track surgery has the potential
to diminish the rate of postoperative complications, the length of stay, and achieve a
similar patient recovery. In an era, where medical costs are on the rise, hospital beds are
limited and nursing staff not always available, fast track surgery has the potential to
improve increase throughput, improve efficiency, decrease costs and improve surgical
productivity.
Currently, at the CHUM - Notre-Dame Hospital, there is no standardized patient care pathway
for patients undergoing VATS lobectomy. The care given to patient prior to the implementation
of this protocol was different amongst patients and depended on the surgeon's preferences.
The implementation of this Enhanced Recovery Program (ERP) will permit a reproducible and
routine management for patients following their surgery.
The principal outcomes that will be compared amongst patients pre and post implementation of
this protocol will be the length of stay and the number of complications. The investigators
think that the results will be different between these two groups. The rational for this is
due to the fact that the patients in this Enhanced Recovery Program will have: (1) their
urinary catheter removed sooner, (2) their thoracic drain removed earlier and (3) they will
be mobilized more quickly. These differences will enable these patients to potentially have
less complications post operatively and decrease their hospital stay.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|